RAPS: FDA Revises Guidance on Special Protocol Assessments
11.05.2016
The draft guidance on the special protocol assessment (SPA) process is an update on guidance from 2002 and delves into the meetings between pharmaceutical or biotech sponsors and the US Food and Drug Administration (FDA) to discuss plans for clinical trials.
SciencePharma
